11:18 AM EST - Zomedica Pharmaceuticals Corp. : Has entered into a development, commercialization and exclusive distribution agreement with Seraph Biosciences, Inc., a human biomedical device company. Under the terms of this agreement, Zomedica will have exclusive global veterinary industry rights to develop and market a novel pathogen detection system in the form of an innovative point-of-care diagnostic instrument. Zomedica Pharmaceuticals Corp.
shares V.ZOM are trading unchanged at $2.50.
